These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24796862)

  • 1. Resveratrol and its metabolites bind to PPARs.
    Calleri E; Pochetti G; Dossou KSS; Laghezza A; Montanari R; Capelli D; Prada E; Loiodice F; Massolini G; Bernier M; Moaddel R
    Chembiochem; 2014 May; 15(8):1154-1160. PubMed ID: 24796862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2α production by porcine endometrium.
    Bogacka I; Bogacki M; Kurzyńska A; Chojnowska K
    Reprod Biol; 2013 Dec; 13(4):309-16. PubMed ID: 24287039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures.
    Oyama T; Toyota K; Waku T; Hirakawa Y; Nagasawa N; Kasuga JI; Hashimoto Y; Miyachi H; Morikawa K
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):786-95. PubMed ID: 19622862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
    Ye F; Zhang ZS; Luo HB; Shen JH; Chen KX; Shen X; Jiang HL
    Chembiochem; 2006 Jan; 7(1):74-82. PubMed ID: 16317783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.
    Cronet P; Petersen JF; Folmer R; Blomberg N; Sjöblom K; Karlsson U; Lindstedt EL; Bamberg K
    Structure; 2001 Aug; 9(8):699-706. PubMed ID: 11587644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different structures of the two peroxisome proliferator-activated receptor gamma (PPARγ) ligand-binding domains in homodimeric complex with partial agonist, but not full agonist.
    Ohashi M; Oyama T; Miyachi H
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2639-44. PubMed ID: 25987371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors.
    Johnson TE; Holloway MK; Vogel R; Rutledge SJ; Perkins JJ; Rodan GA; Schmidt A
    J Steroid Biochem Mol Biol; 1997; 63(1-3):1-8. PubMed ID: 9449199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.
    Tsukahara T; Tsukahara R; Yasuda S; Makarova N; Valentine WJ; Allison P; Yuan H; Baker DL; Li Z; Bittman R; Parrill A; Tigyi G
    J Biol Chem; 2006 Feb; 281(6):3398-407. PubMed ID: 16321982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists.
    Ammazzalorso A; Carrieri A; Verginelli F; Bruno I; Carbonara G; D'Angelo A; De Filippis B; Fantacuzzi M; Florio R; Fracchiolla G; Giampietro L; Giancristofaro A; Maccallini C; Cama A; Amoroso R
    Eur J Med Chem; 2016 May; 114():191-200. PubMed ID: 26974385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma (PPARγ) has multiple binding points that accommodate ligands in various conformations: Structurally similar PPARγ partial agonists bind to PPARγ LBD in different conformations.
    Ohashi M; Gamo K; Oyama T; Miyachi H
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2758-62. PubMed ID: 26025876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.
    Capelli D; Cerchia C; Montanari R; Loiodice F; Tortorella P; Laghezza A; Cervoni L; Pochetti G; Lavecchia A
    Sci Rep; 2016 Oct; 6():34792. PubMed ID: 27708429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy.
    Kurzynska A; Bogacki M; Chojnowska K; Bogacka I
    J Physiol Pharmacol; 2014 Oct; 65(5):709-17. PubMed ID: 25371531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
    Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
    Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PPARα-Ligand Binding Modes Revealed by X-ray Crystallography].
    Kamata S; Ishii I
    Yakugaku Zasshi; 2021; 141(11):1267-1274. PubMed ID: 34719550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors.
    Murakami I; Wakasa Y; Yamashita S; Kurihara T; Zama K; Kobayashi N; Mizutani Y; Mitsutake S; Shigyo T; Igarashi Y
    Lipids Health Dis; 2011 Aug; 10():150. PubMed ID: 21861924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
    Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P
    Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.